Given that sensory or gastrointestinal adverse effects, such as dysgeusia and persistent nausea, can impair nutritional intake and lead to early treatment discontinuation (particularly in vulnerable populations) future research must incorporate rigorous sensory testing, larger and more diverse cohorts, and adherence-related outcomes to clarify how incretin therapies influence taste perception and long-term eating behavior (153, 157, 161)
Whats happening: The GI tract has undergone substantial repair
Rasagiline suppresses mitochondrial apoptosis by inhibiting caspase-3 and nuclear poly [ADP-ribose] polymerase 1 (PARP-1) activation, translocation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), the opening of the MPT and DNA fragmentation (Figure 1
Diabetologia 68, 11151125
[17] Does food intake influence efficacy Oral bioavailability approaches 100 %, but a light meal may delay Tmax by 30 minutes without altering total analgesic effect
Copeland, I